All Vaccinology articles
-
NewsAvian flu could push vulnerable vulture populations into further decline
H5N1 avian influenza is emerging as a serious threat to already vulnerable vulture populations, with deaths reported across the Americas and Europe. Researchers warn that losing these scavengers could also weaken a natural barrier against disease by allowing infected carcasses and pathogens to persist for longer.
-
NewsChildhood measles vaccination rates fall worldwide post COVID-19
Routine vaccine program disruptions and under-resourced health systems are driving a global decline in childhood measles vaccination rates post COVID-19, a study has found.
-
NewsVaccination has little impact on post-COVID smell and taste issues
Researchers examining whether COVID-19 vaccination affects persistent smell or taste problems after contracting the virus have found that, in most cases, it does not.
-
NewsScientific triumph, equity failure: Faster, fairer COVID-19 vaccine roll-out could have saved millions of lives
Beginning the global COVID-19 vaccine roll-out 100 days after the virus was sequenced could have saved more than 8 million lives by the end of 2021, most of them in lower-middle-income countries. The authors of a new Policy Brief argue that fair vaccine-sharing rules should be established before the next pandemic, rather than negotiated during the crisis itself.
-
NewsSkin injection of live flu virus provides durable protection without lung damage
A single subcutaneous injection of a live, unattenuated influenza virus can provide durable protection against lethal flu without causing lung damage, according to new findings that challenge the long-standing trade-off between the safety of inactivated vaccines and the potent immunity of live vaccines.
-
News£4 million awarded to develop vaccines that protect livestock and tackle growing biosecurity threat
Scientists are set to receive £4 million to help tackle the growing biosecurity threat faced by the UK. The project will develop an mRNA vaccine platform for use across major livestock species. This platform will help prepare for future epidemics, tackle antimicrobial resistance, and accelerate the development of next-generation animal vaccines.
-
NewsVaccinating mothers protects offspring from deadly superbug
Researchers found that a vaccine given to pregnant mice protected their newborn pups from a severe bloodstream infection caused by Klebsiella pneumoniae, a dangerous bacterium that kills thousands of infants in low- and middle-income countries each year and is the leading killer of children globally.
-
NewsEbola vaccine induces T cell cross-reactivity against Bundibugyo virus in humans
A vaccine developed against Ebola virus may offer some immune protection against the related Bundibugyo ebolavirus, for which no licensed vaccine currently exists. Researchers found that a single dose triggered T cells capable of recognising BDBV, raising the possibility that existing vaccines could provide a degree of cross-protection during outbreaks.
-
NewsMount Sinai awarded five-year, $20.7 million vaccine development agreement to advance next-generation technologies against respiratory threats
Researchers at the Icahn School of Medicine at Mount Sinai have been awarded a five-year project agreement to develop Vaccine Immunoengineering for Targeted Antigen Presentation and Layered Control (VITAL), a research program exploring an improved approach to vaccination against respiratory pathogens.
-
NewsMalaria remains the leading cause of hospital admission and in-hospital death in children under two in Sierra Leone
Malaria remains the biggest threat to young children in Sierra Leone, accounting for more than half of hospital admissions in a large two-year study. Researchers also found that children who received all routine vaccinations and preventive malaria treatment had a substantially lower risk of dying.
-
NewsValue-aligned messages increased COVID-19 vaccination intentions, study finds
Vaccine-hesitant adults were more likely to consider getting a COVID-19 vaccine when public health messages acknowledged distrust of government and affirmed values such as personal liberty, a new study found.
-
NewsThe benefits of vaccination extend beyond protection from infection
A study, carried out in mice, shows how after recovering from an acute viral infection, animals experienced a long period of impaired immune responsiveness which compromised their immune system’s ability to effectively respond to future challenges. Prior vaccination prevented these detrimental consequences, preserving immune function.
-
NewsGlobal study finds stark differences in RSV vaccine uptake
Vaccination against respiratory syncytial virus during pregnancy lowers the risk of severe disease in babies by 74 per cent, but uptake in many countries remains low, according to a review revealing evidence of lower uptake among some socioeconomic and ethnic groups, those with reduced access to healthcare, and mothers of a younger age.
-
NewsHPV vaccination before pregnancy linked to lower risk of preterm birth and other major complications
Having received the human papillomavirus (HPV) vaccine before pregnancy is associated with a lower risk of major pregnancy complications including preterm birth, with the greater reduction in risk seen among women vaccinated at an earlier age, finds a large Swedish study.
-
NewsMaternal vaccines protect babies from serious infections, but unequal access limits benefits across Europe
Europe must act now to strengthen maternal vaccination in pregnancy and ensure all women and babies can benefit from a new generation of vaccines to protect against serious infections, says a new series being launched today.
-
NewsChiba University and Noguchi Memorial Institute for Medical Research partnership targets next-generation vaccines
Chiba University and the University of Ghana’s Noguchi Memorial Institute for Medical Research have launched a new research partnership aimed at advancing next-generation vaccines, therapeutics and diagnostics. The collaboration will connect expertise in Japan and Ghana to strengthen infectious disease research, researcher training and global health innovation.
-
NewsEven modest post-infection complications can make expanded vaccine coverage cost effective: New modelling
New modelling could help public health officials better factor in the long-term impacts of infectious disease when determining optimum vaccine coverage rates. Even small post-infection costs can tip the scales and make the case for vaccine-driven elimination, the study shows.
-
NewsNew genetic platform could pave the way for better HPV vaccines
Scientists have developed a new genetic platform that could pave the way for more stable, efficient and widely available HPV vaccines, helping address persistent global shortages. The approach allows researchers to generate and select promising virus variants with traits that could improve future vaccine production and storage.
-
NewsCOVID-19 immunity may help protect against other bat coronaviruses
Scientists have found that bat coronaviruses most likely to infect a wide range of animal species are those most closely related to SARS-CoV-2 and most likely to be recognised by immunity generated through COVID-19 infection.
-
NewsHeel-prick blood samples from newborns could provide important insights into protection against serious infection
Heel-prick blood samples from newborns can be used to measure antibodies against Group B Streptococcus, according to a new study. In the longer term, the method could contribute to the development of vaccines designed to protect infants against serious infections.